- Home
- BEEM vs ATHA Comparison
BEEM vs ATHA Comparison
Compare BEEM & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- ATHA
- Stock Information
- Founded
- BEEM 2006
- ATHA 2011
- Country
- BEEM United States
- ATHA United States
- Employees
- BEEM N/A
- ATHA N/A
- Industry
- BEEM Semiconductors
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- BEEM Technology
- ATHA Health Care
- Exchange
- BEEM Nasdaq
- ATHA Nasdaq
- Market Cap
- BEEM 21.7M
- ATHA 21.0M
- IPO Year
- BEEM N/A
- ATHA 2020
- Fundamental
- Price
- BEEM $1.96
- ATHA $0.26
- Analyst Decision
- BEEM Strong Buy
- ATHA Buy
- Analyst Count
- BEEM 3
- ATHA 4
- Target Price
- BEEM $9.00
- ATHA $11.25
- AVG Volume (30 Days)
- BEEM 123.6K
- ATHA 214.5K
- Earning Date
- BEEM 05-23-2025
- ATHA 05-09-2025
- Dividend Yield
- BEEM N/A
- ATHA N/A
- EPS Growth
- BEEM N/A
- ATHA N/A
- EPS
- BEEM N/A
- ATHA N/A
- Revenue
- BEEM $49,336,000.00
- ATHA N/A
- Revenue This Year
- BEEM $27.41
- ATHA N/A
- Revenue Next Year
- BEEM $58.00
- ATHA N/A
- P/E Ratio
- BEEM N/A
- ATHA N/A
- Revenue Growth
- BEEM N/A
- ATHA N/A
- 52 Week Low
- BEEM $1.33
- ATHA $0.22
- 52 Week High
- BEEM $7.68
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- BEEM 65.82
- ATHA 45.40
- Support Level
- BEEM $1.40
- ATHA $0.23
- Resistance Level
- BEEM $1.48
- ATHA $0.30
- Average True Range (ATR)
- BEEM 0.09
- ATHA 0.03
- MACD
- BEEM 0.09
- ATHA 0.00
- Stochastic Oscillator
- BEEM 93.33
- ATHA 37.12
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.